Medicine and Dentistry
Abatacept
16%
Acute Graft Rejection
16%
Adaptive Immunity
10%
Allograft
19%
Alzheimer's Disease
32%
Amyotrophic Lateral Sclerosis
36%
Aneurysm
16%
Apoplexy
16%
Bile Duct
8%
Biological Marker
20%
Brain Ischemia
12%
Brain Metastasis
16%
Combination Therapy
16%
Common Hepatic Artery
12%
Diseases
19%
Ex Vivo
48%
Gastrointestinal Cancer
16%
Glutamic Acid
11%
Hepatic Portal Vein
12%
HTK Solution
16%
Hypothermia
8%
Immunosuppressive Drug
18%
In Vitro
16%
Induced Hypothermia
16%
Inferior Vena Cava
16%
Interleukin 18
8%
Interleukin 2
17%
Intracranial Aneurysm
16%
Intranasal Drug Administration
8%
Kidney Graft
16%
Kidney Transplantation
32%
Lactic Acid
24%
Light Chain
8%
Living Donor
16%
M2 Macrophages
16%
Macrophage
9%
Microglia
8%
Neuroprotective Agent
14%
Oxidative Stress
8%
Parkinson's Disease
16%
Polycystic Kidney Disease
16%
Pyruvic Acid
17%
Regulatory T Cell
40%
Regulatory T Lymphocyte
16%
Semantic Dementia
16%
Serositis
16%
Survival Rate
10%
Systematic Review
16%
Thrombosis
16%
Traumatic Brain Injury
16%
Immunology and Microbiology
Abatacept
16%
Acute Graft Rejection
16%
Acute Phase Protein
32%
Adaptive Immune System
6%
Blood Level
8%
CD14
9%
CD25
12%
CD4
6%
Cell Death
16%
Cold Ischemia
26%
Dendritic Cell
16%
Disease Burden
12%
Disease Registry
16%
Glucose Level
10%
Glycerol
37%
Immunity
10%
Immunosuppressant
8%
Immunosuppressive Drug
20%
Induced Pluripotent Stem Cell
13%
Inflammation Response
20%
Interleukin 18
8%
Interleukin 2
17%
Kidney Transplantation
80%
Light Chain
8%
Low-Density Lipoprotein
8%
M2 Macrophages
16%
Macrophage
9%
Metabolite
24%
Microdialysis
64%
Microglia
6%
Myeloid
5%
Nerve Cell Degeneration
5%
Neurofilament
8%
Oxidative Stress
24%
Porcine Model
52%
Precuneus
16%
Programmed Cell Death 1
5%
Programmed Death-Ligand 1
5%
Regulatory T Cell
100%
Reperfusion
29%
Solution and Solubility
16%
Steady State
5%
Systemic Inflammation
5%
Keyphrases
18F-florbetaben PET
5%
Acute Phase Proteins
16%
Amyotrophic Lateral Sclerosis
16%
Average Rate of Change
6%
Behet's Disease
16%
Bretschneider's Solution
8%
Clinical Grade
16%
Cold Ischemia
16%
Comparative Experimental Study
16%
Custodiol
8%
Deceased Donor
12%
Dendritic Cells
16%
Disease Burden
6%
Disease Progression
6%
Disease Severity
16%
Donor Groups
16%
Experimental Porcine Model
16%
Extracellular Vehicles
12%
Flow Diversion Stent
5%
Glycerol
5%
HTK Solution
16%
HTK-N
16%
Human Leukocyte Antigen B51
16%
Imag
5%
Immunogenic
16%
Interleukine-2
16%
International Criteria
16%
Intervention Options
5%
Intravascular Cooling
8%
Iran
16%
Kidney Transplant Recipients
16%
Kidney Transplantation
16%
Living Donor
12%
Microdialysis
16%
Peripheral Disease
16%
Peripheral Inflammation
16%
Phase I/IIa Study
5%
Polycystic Kidney Disease
16%
Restorable
5%
Semantic Dementia
16%
Semantic Variant Primary Progressive Aphasia
13%
Soluble CD14 (sCD14)
6%
Stress Phase
16%
Technical Guidelines
16%
Tolerogenic
16%
Tolerogenic Dendritic Cells
6%
Tubular Regeneration
8%
Wisconsin Solution
8%
